hScheie Eye Institute and Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA iDepartment of Ophthalmology, Bahir Dar University College of ...

FTCC’s Respiratory Therapy Program is growing, and that means more chances for you to launch a rewarding, hands-on healthcare career that makes a real difference in people’s lives. Respiratory ...

The percentage of adults and adolescents with CF using only 1 or fewer respiratory therapies went from 13.8% pre-ETI to 53.4% at 54 months post-ETI. Elexacaftor ...

Please provide your email address to receive an email when new articles are posted on . Chronic respiratory therapies included inhaled antibiotics, hypertonic saline, dornase alfa and oral ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the best stocks to buy for the next 5 years. On December 15, Goldman Sachs raised the firm’s price target on Bristol-Myers Squibb to $57 from $51, ...

The central challenge to internationalizing China’s health care lies in the absence of an end-to-end, one-stop service pathway for international patients, spanning professional licensure, drug and ...

King County Executive Girmay Zahilay gave a shout out this week to a county employee who went above and beyond in the midst of area flooding. Tyler Stiltner is the senior operator in charge at the ...

LAKE CHARLES, La. (KPLC) - SOWELA has now received approval from the Southern Association of Colleges and Schools Commission on Colleges to offer an Associate of Applied Science in Respiratory Care.

The FDA has approved lisocabtagene maraleucel (Breyanzi, Bristol-Myers Squibb) for relapsed or refractory marginal zone lymphoma (MZL) in adults after at least two prior lines of systemic therapy.